John Vavricka, Chief Commercial Officer: Atea Pharmaceuticals AVIR Sell · Filed 24/02/02

Trade details

Type: Insider sale
Amount: $45,384.96
Shares · price: 11,819 sh · $3.84 a share
Held after: 21,515 sh
Stock: Atea Pharmaceuticals AVIR
Person: John VavrickaChief Commercial Officer
Trade date: 24/02/01
Filed: 24/02/02
Days to filing: 1 days

Sold 35.5% of holdings

Share of holding sold: 35.5%

Atea Pharmaceuticals trades, last 26 weeks

What else happened in Atea Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/02~24/03/02

John Vavricka's recent trades

No other trades yet.